This book delves into the delicate realm of neurodegenerative illnesses, navigating the vast landscape of molecular targets with care and purpose. Researchers are studying the complex pathways involved in diseases such as Alzheimer's, Parkinson's, and Huntington's in order to identify specific molecules that could be targeted for therapy. The present work explores potential methods of intervention by carefully analysing neural circuits, protein misfolding, and genetic predispositions, unravelling the complexities of the human mind by focusing on individual molecular targets. As new findings emerge, reducing the severe consequences of neurodegenerative illnesses becomes increasingly possible, providing optimism for millions of people throughout the world.
Dr Prashant Tiwari, PhD, is Associate Professor of Pharmacology at Dayananda Sagar University, College of Pharmaceutical Sciences in Bengaluru, India. He was a regular fellow of the Indian Council of Medial Research. Along with 13 years of teaching and research experience, Dr Tiwari specializes in drug screening and brain cell drug delivery assessment. He has authored 6 books, edited 4 books, co-authored 6 book chapters, and created 7 patents and 2 grants. Dr Tiwari is associated with LASAI, INS, APTI, IPES, SPER, and ERDA (national and international organisations). Drug interactions, PK/PD, metabolic diseases, and neurodegenerative disorders are his research interests.Dr K Sunil Kumar is a Professor at Dayananda Sagar University, College of Pharmaceutical Sciences in Bengaluru, Karnataka, India. He has 16 years of teaching experience. His focus is on neuropharmacology and drug interactions. He earned a PhD in Pharmaceutical sciences from Jawaharlal Nehru Technological University Hyderabad, India. He has published 60 research and review articles, 5 books and 4 patents.
